Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.46 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Zhengye Biotechnology Holding (ZYBT) Receivables (2023 - 2025)

Updated

Zhengye Biotechnology Holding (ZYBT) posted Receivables of $2.71 million for the quarter ended Dec 31, 2025, down 67.7% from $8.39 million a year earlier.

Analysis

Zhengye Biotechnology Holding (ZYBT) Receivables (2023 - 2025) Analysis & Trends

As of Dec 31, 2025, Zhengye Biotechnology Holding's Receivables came in at $5.83 million, down 30.6% from the prior year.

  • In prior years, Zhengye Biotechnology Holding's Receivables was $8.39 million in the year ended Dec 31, 2024 (-21.4%) and $10.68 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 18.99 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 13.82 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 15.68 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 5.06 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 12.49 Bn
10 Zhengye Biotechnology Holding 69.19 Mn 65.60 Mn - 2.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.75 Mn
Jun 30, 2025 5.25 Mn
Dec 31, 2024 8.26 Mn
Dec 31, 2023 10.62 Mn
API Access

Zhengye Biotechnology Holding Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ZYBT&period=max&api_key=YOUR_API_KEY